切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2011, Vol. 05 ›› Issue (02) : 180 -188. doi: 10.3877/cma.j.issn.1674-0807.2011.02.009

临床研究

腔镜与开放性手术切除乳腺癌内乳淋巴链的对比研究
张在鸿1, 杨新华1, 张毅1, 范林军1, 张帆1, 陈莉1, 周艳1, 高寒1, 明佳1, 姜军1,()   
  1. 1.400038 重庆,第三军医大学西南医院乳腺疾病中心
  • 收稿日期:2011-03-15 出版日期:2011-04-01
  • 通信作者: 姜军

A pilot clinical study comparing endoscopic surgery with open surgurey in internal mammary lymph chain of breast cancer

Zai-hong ZHANG1, Xin-hu YANG1, Yi ZHANG1, Ling-jun FAN1, Fan ZHANG1, Li CHEN1, Yan ZHOU1, Han GAO1, Jia MING1, Jun JIANG1,()   

  1. 1.Breast Disease Center, Southwest Hospital, Third Military Medical University, Chongqing 400038,China
  • Received:2011-03-15 Published:2011-04-01
  • Corresponding author: Jun JIANG
引用本文:

张在鸿, 杨新华, 张毅, 范林军, 张帆, 陈莉, 周艳, 高寒, 明佳, 姜军. 腔镜与开放性手术切除乳腺癌内乳淋巴链的对比研究[J/OL]. 中华乳腺病杂志(电子版), 2011, 05(02): 180-188.

Zai-hong ZHANG, Xin-hu YANG, Yi ZHANG, Ling-jun FAN, Fan ZHANG, Li CHEN, Yan ZHOU, Han GAO, Jia MING, Jun JIANG. A pilot clinical study comparing endoscopic surgery with open surgurey in internal mammary lymph chain of breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2011, 05(02): 180-188.

目的

对比乳腺癌改良根治术+腔镜下内乳淋巴链切除术与乳腺癌扩大或改良扩大根治术的临床疗效,探讨更适合于乳腺癌内乳淋巴结转移高风险患者的术式。

方法

取2004年6月至2010年11月在本科住院确诊为乳腺癌且内乳淋巴结转移高风险的患者共97 例,其中50 例行乳腺癌改良根治+腔镜下内乳淋巴链切除术(腔镜组),47 例实施乳腺癌扩大或改良扩大根治术(开放组)。记录两种术式的手术时间、术中出血量、清除的内乳淋巴结数目、术后引流时间、术后恢复时间、术后VAS 疼痛评分、术后并发症等指标并进行比较。定量资料比较采用t 检验或Mann-Whitney U 检验,定性资料比较采用χ2检验。

结果

入组97 例患者均顺利完成手术,无器官损伤及术后出血等严重并发症。腔镜组术后72 h VAS 疼痛评分比开放组低 (Z=2.26,P=0.02)。两组手术时间、术中出血量、清除内乳淋巴结数目、术后引流时间、术后恢复时间、术后24 h 疼痛评分及并发症等指标比较,差异均无统计学意义(P>0.05)。术后随访6 ~15个月,中位随访12 个月,入组患者均无复发、远处转移或死亡。

结论

乳腺癌改良根治术后经腔镜下行内乳淋巴链切除术安全可行、创伤小,疗效不劣于开放手术。

Objective

To compare the clinical efficacy between modified radical mastectomy plus endoscopic resection of internal mammary lymph chain and extended or modified radical mastectomy in order to find more suitable surgery for breast cancer patients with high risk of internal mammary lymph node metastasis.

Methods

Ninety-seven breast cancer patients with high risk of internal mammary lymph node metastases were collected in the Breast Disease Center of Southwest Hospital from June 2004 to November 2010.Among them,50 patients underwent modified radical mastectomy plus endoscopic resection of internal mammary lymph chain (the endoscopic surgery group),and 47 patients underwent extended or modified radical mastectomy (the open surgery group).The operative duration,the volume of intraoperative blood loss,the number of internal mammary lymph nodes resected,postoperative drainage time,postoperative recovery time,postoperative pain score and postoperative complications were recorded and compared between the two groups. Statistical analysis was performed using t test or Mann-Whitney U test for quantitative data and chi square test for qualitative data.

Results

Operations were completed successfully in all the 97 patients,and no organ damage,postoperative bleeding or other serious complications were found. The 72 hour pain scores after surgery in the endoscopic surgery group were lower than in the open surgery group (Z=2.26,P=0.02). There were no statistically significant differences in the average operation duration,the mean blood loss,the average number of internal mammary lymph nodes resected,postoperative drainage time,postoperative recovery time,postoperative 24-hour pain score and complications between the two groups(P>0.05). The follow-up of 6-15 months (mean 12 months) showed no recurrence,distant metastasis or death in both groups.

Conclusion

Endoscopic resection of internal mammary lymph chain after modified radical mastectomy is safe and feasible,with less invasion and similar therapeutic effect with the open surgery.

表1 腔镜组与开放组的临床资料比较 (例)
图1 分离内乳血管
图2 夹闭内乳血管
图3 乳腺癌扩大根治术
图4 乳腺癌改良扩大根治术
表2 腔镜组与开放组的观察指标比较
[1]
Sugg SL,Furguson DJ,Posner,MC,et al. Should internal mammary nodes be sampled in the sentinel lymph node era?[J]. Surg Oncol,2000,7(3):188-192.
[2]
Yao MS,Kurland BF,Smith AH,et al. Internal mammary nodal chain drainage is a prognostic indicator in axillary node positive breast cancer [J]. Ann Surg Oncol,2007,14(10): 2985-2993.
[3]
CranenbroekS,vander Sangen MJ,Kuijt GP,et al. Diagnosis,treatment and prognosis of internal mammary lymph node recurrence in breast cancer patients [J]. Breast Cancer Res Treat,2005,89 (3): 271-275.
[4]
Singletary SE,Allred C,Ashley P,et al. Revision of the American Joint Committee on Cancer Staging System for Breast Cancer [J]. J Clin Oncol,2002,20 (17) : 3628-3636.
[5]
Greene FL,Page DL,Fleming ID,et al. AJCC Cancer Staging Manual [M]. 6th ed. New York: Springer,2002: 221-240.
[6]
Long H,Lin Z,Situ D,et al. Stage migration and therapy modification after thoracoscopic internal mammary lymph node dissection in breast cancer patients [J]. Breast,2011,20(2): 129-133.
[7]
Huang O,Wang L,Shen K,et al. Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2269 Chinese breast cancer patients treated with extended radical mastectomy [J]. Breast Cancer Res Treat,2008,107(3): 379-387.
[8]
贺青卿,杨新华,郭美琴,等. 胸腔镜内乳淋巴链清扫的临床研究[J]. 第三军医大学学报,2005,27(22):2290-2292.
[9]
He Q,Jiang J,Yang X,et al. A pilot study on thoracoscopic internal mammary lymphatic chain dissection for breast cancer [J]. Breast,2008,17(6):568-573.
[10]
中华医学会外科学分会内分泌外科学组. 乳腺疾病腔镜手术技术操作指南(2008 版)[J /CD ]. 中华乳腺病杂志:电子版,2009,3 (1) : 95-105.
[11]
Chen RC,Lin NU,Golshan M,et al. Internal mammary nodes in breast cancer: diagnosis and implications for patient management: a systematic review [J]. J Clin Oncol,2008,26(30):4981-4989.
[12]
姜军.乳腺癌内乳淋巴结转移的诊治进展[J].中国实用外科杂志,2006,26(4): 265-267.
[13]
Laino C. Answering a long-time question,study finds no benefit for post-mastectomy radiation therapy to internal mammary nodes[J]. Oncology Times,2009,31(24):44.
[14]
Giordano SH,Kuo YF,Freeman JL,et al: Risk of cardiac death after adjuvant radiotherapy for breast cancer [J]. Natl Cancer Inst,2005,97(6):419-424.
[15]
Kelley M C,Hansen N,McMasters KM. Lymphatic mapping and sentinel lymphadenectomy for breast cancer [J]. Am J Surg,2004,188(1): 49- 61.
[16]
Goyal A,Newcombe RG,Mansel RE,et al. Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer [J].Eur J Cancer,2005,41( 2): 238-243.
[17]
郭美琴,杨新华,贺青卿,等. 胸腔镜内乳前哨淋巴结活检和内乳淋巴链切除的实验研究[J]. 中国微创外科杂志,2006,6(3): 226-228.
[18]
姜军. 腔镜技术在乳腺疾病治疗中的地位及其评价[J]. 中国实用外科杂志,2010,30(3): 195-197.
[19]
姜军.腔镜技术在乳腺癌外科治疗中的应用[J].外科理论与实践,2008,13(2):106-107.
[20]
姜军. 乳腺癌扩大根治术的评价和应用前景[J]. 中国普外基础与临床杂志,2001,8 (5) : 335-336.
[21]
Schmid SM,Modlasiak AA,Myrick ME,et al. Success and failure of primary medical nonoperative management in breast cancer[J]. Ann Surg Oncol,2011.[2011-03-01]http:/ /www.springerlink.com/content/k68h2x4517650ru6/fulltext.pdf.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[3] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[4] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[5] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[6] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[7] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[8] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[9] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[10] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[11] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[12] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[13] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[14] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[15] 韩俊岭, 王刚, 马厉英, 连颖, 徐慧. 维生素D 联合匹维溴铵治疗腹泻型肠易激综合征患者疗效及对肠道屏障功能指标的影响研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 560-564.
阅读次数
全文


摘要